|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/6874 | |
| C12Q 1/6881 | |||
| C12Q 1/6888 | |||
| A61K 39/00 | |||
| A61K 35/17 | |||
| G06F 19/18 |
| (11) | Patento numeris | 2872653 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13817114.5 |
| Europos patento paraiškos padavimo data | 2013-07-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-05-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/050362 |
| Data | 2013-07-12 |
| (87) | Numeris | WO 2014/012051 |
| Data | 2014-01-16 |
| (30) | Numeris | Data | Šalis |
| 201261670931 P | 2012-07-12 | US |
| (72) |
VITIELLO, Maria, Antonia, US
|
| (73) |
Persimmune, Inc.,
11555 Sorrento Valley Road, San Diego, CA 92121,
US
|
| (54) | PERSONALIZED CANCER VACCINES AND ADOPTIVE IMMUNE CELL THERAPIES |
| PERSONALIZED CANCER VACCINES AND ADOPTIVE IMMUNE CELL THERAPIES |